SPONSOR
Kind Pharmaceuticals LLC
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 3, Phase 1
Conditions studied: Myelodysplastic SyndromesAnemia Due to Chronic Kidney DiseaseAdvanced or Metastatic Breast Cancer
NCT06304103 Phase 2
Recruiting
A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome
Myelodysplastic Syndromes
NCT07494409 Phase 3
Recruiting
A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia
Anemia Due to Chronic Kidney Disease
NCT05187832 Phase 1
Recruiting
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
Advanced or Metastatic Breast Cancer